Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review

Nicotine and Tobacco Research

Volumn 12, Issue 7, 2010, Pages 756-762

  Hughes, John R ^a   Carpenter, Matthew J ^b,c   Naud, Shelly ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSTINENCE; ARTICLE; HUMAN; PREVALENCE; PRIORITY JOURNAL; SMOKING CESSATION; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; FOLLOW UP; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVENTION AND CONTROL; RISK; SMOKING; STATISTICS AND NUMERICAL DATA; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

NICOTINE; NICOTINIC AGENT;

CLINICAL TRIALS AS TOPIC; FOLLOW-UP STUDIES; HUMANS; NICOTINE; NICOTINIC AGONISTS; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 77955240140     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntq078     Document Type: Article

References (25)

1. Balk, E. M., Bonis, P. A. L., Moskowitz, H., Schmid, C. H., Ioannidis, J. P. A., Wang, C., et al. (2002). Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. Journal of the American Medical Association, 287, 2973-2982.
2. Fagerstrom, K., & Hughes, J. R. (2008). Varenicline in the treatment of tobacco. Neuropsychiatric Disease and Treatment, 4, 1-11.
3. Fiore, M., Jaen, C., Baker, T., Bailey, W., Benowitz, N., Curry, S., et al. (2008). Treating tobacco use and dependence: Clinical practice guideline. Washington, DC: US Public Health and Human Services.
4. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. Journal of the American Medical Association, 271, 1940-1946.
5. Fisher, K. J., Glasgow, R. E., & Terborg, J. R. (1990). Worksite smoking cessation: A meta-analysis of long-term quit rates from controlled studies. Journal of Occupational Medicine, 32, 429-439.
6. Fleiss, J. (1994). Measures of effect size for categorical data. In H. Cooper & L. Hedges (Eds.), The handbook of research synthesis (pp. 245-260). New York: Russell Sage Foundation.
7. Hughes, J. (2009). How confident should we be that smoking cessation treatments work? Addiction, 104, 1637-1640.
8. Hughes, J., Peters, E., & Naud, S. (2008). Relapse to smoking after 1 year of abstinence: A meta-analysis. Addictive Behaviors, 33, 1516.
9. Hughes, J. R., & Callas, P. W. (2007). Errors in interpreting abstinence curves in studies of smoking cessation. Nicotine & Tobacco Research, 8, 7-12.
10. Hughes, J. R., Keely, J., & Naud, S. (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction, 99, 29-38.
11. Hughes, J. R., Keely, J., Niaura, R., Ossip-Klein, D., Richmond, R., & Swan, G. (2003). Measures of abstinence from tobacco in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, 13-25.
12. Mermelstein, R. J., Colby, S. M., Patten, C., Prokhorov, A., Brown, R., Myers, M., et al. (2002). Methodological issues in measuring treatment outcome in adolescent smoking cessation studies. Nicotine & Tobacco Research, 4, 395-403.
13. Ockene, J. K., Emmons, K. M., Mermelstein, R. J., Perkins, K. A., Bonollo, D. S., Voorhees, C. C., et al. (2000). Relapse and maintenance issues for smoking cessation. Health Psychology, 19, 17-31.
14. Ossip-Klein, D. J., Bigelow, G., Parker, S. R., Curry, S., Hall, S., & Kirkland, S. (1986). Classification and assessment of smoking behavior. Health Psychology, 5, 3-11.
15. Raudenbush, S., Bryk, A., Cheong, Y., Congdon, R., & du Toit, M. (2004). HLM 6: Linear and nonlinear modeling. Lincolnwood, IL: Scientific Software International, Inc.
16. Richmond, R. L. (1997). A comparison of measures used to assess effectiveness of the transdermal nicotine patch at 1 year. Addictive Behaviors, 22, 753-757.
17. Shadish, W. R., & Haddock, C. K. (1994). Combining estimates of effect size. In H. Cooper & L. V. Hedges (Eds.), The handbook of research synthesis (pp. 261-281), New York: Russell Sage Foundation.
18. Shiffman, S., Scharf, D., Shadel, W., Gwaltney, C., Dang, Q., Paton, S., et al. (2006). Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. Journal of Consulting and Clinical Psychology, 74, 276-285.
19. Shipley, R. H., Rosen, T. J., & Williams, C. (1982). Measurement of smoking: Surveys and some recommendations. Addictive Behaviors, 7, 299-302.
20. Thompson, S., & Higgins, J. (2002). How should meta-regression analyses be undertaken and interpreted? Statistics in Medicine, 21, 1559-1573.
21. Velicer, W. F., & Prochaska, J. O. (2004). A comparison of four smoking cessation outcome measures. Addictive Behaviors, 29, 51-60.
22. Velicer, W. F., Prochaska, J. O., Rossi, J. S., & Snow, M. G. (1992). Assessing outcome in smoking cessation studies. Psychological Bulletin, 111, 23-41.
23. West, R., Baker, C., Cappelleri, J., & Bushmakin, A. (2008). Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology, 197, 371-377.
24. West, R., Hajek, P., Stead, L., & Stapleton, J. (2005). Outcome criteria in smoking cessation trials: Proposal for a common standard. Addiction, 100, 299-303.
25. West, R., McNeill, A., & Raw, M. (2000). Smoking cessation guidelines for health professionals: An update. Thorax, 55, 987-999.